Genertec Universal Medical Group Company Limited (HKG: 2666)

Market Cap	9.14B
Revenue (ttm)	14.19B
Net Income (ttm)	2.21B
Shares Out	1.89B
EPS (ttm)	1.09
PE Ratio	4.42
Forward PE	4.03
Dividend	0.35 (7.06%)
Ex-Dividend Date	n/a

Volume	3,089,000
Open	5.020
Previous Close	5.010
Day's Range	4.950 - 5.020
52-Week Range	3.710 - 5.870
Beta	0.68
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Genertec Universal Medical Group Company

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance Business and Healthcare Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Healthcare Business segment engages in medical and healthcare services; hospital operation; import, export, and domestic trading of medical-related goods; equipment life cycle managemen...

• Industry: Financial - Credit Services
• Sector: Financials
• Founded: 1984
• Employees: 21,089
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2666

Financial Performance

In 2023, Genertec Universal Medical Group Company's revenue was 13.42 billion, an increase of 14.40% compared to the previous year's 11.73 billion. Earnings were 2.02 billion, an increase of 7.02%.

Financial numbers in CNY